| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aef581b82356b48f844563a1528e9f95
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e8eed5ca129929203aaaf15ede1c2e1c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_262a3f661950d64f743d258c360630bf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f2ca4d6fb242d282ec6657bb24b4c8f9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d43cd5ade07370afaf26c339dfe98a18 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-06 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0034
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-522
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-22 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-522
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-06 |
| filingDate |
2008-09-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ca9d9fa5ddeed2be02a35e39c16b9682
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6d8492d2926a41255b6e2604f628a846
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ad509f740d79d753145c97be19f405fc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b8b370725cb4501daaa5a60f1090a385 |
| publicationDate |
2009-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2009031006-A2 |
| titleOfInvention |
Antiviral topical formulations in the form of a bio-adhesive gel |
| abstract |
The invention relates to topical formulations in the form of a bioadhesive hydrophilic gel comprising acyclovir as active ingredient, Sodium hyaluronate and an acrylic polymer. Said formulations improve the local administration of acyclovir in the treatment of herpes infections, because they possess good properties of adherence to the mucosa and high resistance to physiological removal mechanisms. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3417855-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013046161-A1 |
| priorityDate |
2007-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |